1428
S. Tripathy, A. Chattopadhyay / Tetrahedron: Asymmetry 23 (2012) 1423–1429
(99.99% pure ingot, Alfa Aesar, 632 mg, 5.5 mmol). The reaction
mixture was stirred for 48 h. No reaction took place (TLC).
(175 MHz CDCl3): 29.2, 39.5, 62.9, 71.7, 78.6, 78.7, 78.8, 127.8,
127.9, 128.5, 137.8; Anal. Calcd for C13H18O4; C, 65.53; H, 7.61;
Found: C, 65.70; H, 7.45.
4.12. (1S,2S,3R,4R)-1-O-Benzyl-2-O-tert-butyldimethylsilyl-4-
vinyl-cyclopentane-1,2,3-triol 10a and (1S,2S,3R,4S)-1-O-benzyl-
2-O-tert-butyldimethylsilyl-4-vinyl-cyclopentane-1,2,3-triol
10b
4.16. (1S,2S,3S,4R)-4-Hydroxymethyl)-cyclopentane-1,2,3-triol
11a [Carba-a-D-xylofuranose I]
A solution of 11 (125 mg) in EtOH (20 ml) was treated with 10%
Pd-C (20 mg). The mixture was stirred under H2 atmosphere for
10hr until the reaction was complete (monitored by TLC). The mix-
ture was filtered through a Celite pad and solvent was removed un-
der reduced pressure. The residue was chromatographed to afford
1H NMR (200 MHz CDCl3): d 0.06 (br s, 6H), 0.93 (br s, 9H), 1.61–
1.64 (m, 1H), 2.1–2.5 (m, 2H, overlapped with a br s, 1H), 3.65–3.70
(m, 1H), 3.81–3.84 (m, 1H), 4.0 (m, 1H), 4.53–4.65 (m, 2H), 4.9–5.1
(m, 2H), 5.73–5.86 (m, 1H), 7.25–7.34 (m, 5H); 13C NMR (50 MHz
CDCl3): ꢀ4.9, ꢀ4.6, 18.3, 25.9, 32.8, 48.1, 71.7, 72.1, 75.1, 75.9,
77.2, 77.6, 78.9, 79.2, 113.9, 127.4, 127.5, 128.2 138.5, 138.6, 140.6.
pure I (73 mg, 93.9%) as a colorless oil. ½a D26
¼ þ12:7 (c 1.0, MeOH)
ꢂ
[lit.,6d
½
a 2D0
ꢂ
¼ þ12:1 (c 0.7, MeOH)]; 1H NMR (600 MHz D2O): d 1.61
(m, 2H), 2.28–2.31 (m, 1H), 3.36 (dd, J = 7.2 Hz, 10.2 Hz, 1H),
3.53(dd, J = 7.2 Hz, 10.2 Hz, 1H), 3.72(m, 1H), 3.99 (m, 2H); 13C
NMR (150 MHz, D2O): 34.7, 41.8, 64.3, 73.3, 78.5, 81.1.
4.13. (1S,2S,3S,4R)-1-O-Benzyl-2-O-tert-butyldimethylsilyl-4-
vinyl-cyclopentane-1,2,3-triol 10c
½
a 2D4
ꢂ
¼ þ3:8 (c 0.51, CHCl3); 1H NMR (200 MHz CDCl3): d 0.09
4.17. (1S,2S,3S,4S)-1-O-Benzyl-4-hydroxymethyl-cyclopentane-
1,2,3-triol 12
(br s, 6H), 0.91 (br s, 9H), 1.6–2.1 (m, 2H, overlapped with a br s,
1H), 3.10 (m, 1H), 3.94–4.06 (m, 3H), 4.53, 4.64 (AB q, J = 12.0 Hz,
2H), 5.1–5.2 (m, 2H), 5.7–5.9 (m, 1H), 7.2–7.4 (m, 5H); 13C NMR
(50 MHz CDCl3): ꢀ4.8, ꢀ4.7, 18.2, 25.8, 32.2, 42.8, 71.7, 78.2,
79.1, 79.2, 116.8, 127.2, 127.5, 127.6 128.1, 129.6, 134.7, 137.7,
138.9 Anal. Calcd for C20H32O3Si; C, 68.92; H, 9.25; Found: C,
68.71; H, 9.15.
Following the same reactions protocol as carried out for the
preparation of 11, compound 10d (348 mg, 1.0 mmol) was trans-
formed into 12 (179 mg, 75.3%) as a colorless oil. ½a D27
¼ þ29:2 (c
ꢂ
2.16, CH2Cl2); 1H NMR (700 MHz CDCl3): d 1.48 (m, 1H), 1.64 (br
s, 1H), 1.92(m, 1H), 2.06 (m, 1H), 3.57 (m, 1H), 3.63–3.70 (m, 1H,
overlapped with a br s, 2H), 3.82(m, 1H), 3.88–3.90 (m, 1H), 3.93
(t, J = 7 Hz, 1H), 4.47 (d, J = 11.9 Hz, 1H), 4.574 (dd, J = 11.9 Hz,
5.6 Hz, 1H), 7.26–7.34 (m, 5H); 13C NMR (175 MHz CDCl3): 29.4,
43.3, 62.6, 71.6, 77.49, 78.6, 79.6, 127.8, 127.9, 128.5, 137.8; Anal.
Calcd for C13H18O4; C, 65.53; H, 7.61; Found: C, 65.41; H, 7.79.
4.14. (1S,2S,3S,4S)-1-O-Benzyl-2-O-tert-butyldimethylsilyl-4-
vinyl-cyclopentane-1,2,3-triol 10d
½
a 2D5
ꢂ
¼ þ12:95 (c 1.39, CHCl3); 1H NMR (200 MHz CDCl3): d 0.10
(br s, 6H), 0.94 (br s, 9H), 1.62–1.69 (m, 1H, overlapped with a br s,
1H), 2.16–2.26 (m, 2H), 3.74–3.93 (m, 3H), 4.59 (d, J = 5.5 Hz, 2H),
4.97–5.11 (m, 2H), 5.72–5.91 (m, 1H), 7.25–7.35 (m, 5H); 13C NMR
(50 MHz CDCl3): ꢀ4.68, ꢀ4.63, 18.2, 25.8, 33.2, 45.2, 71.4, 77.2,
79.6, 80.5, 114.8, 127.3, 127.6, 128.2, 138.7, 140.9; Anal. Calcd for
4.18. (1S,2S,3S,4S)-4-Hydroxymethyl-cyclopentane-1,2,3-triol
[Carba-a-L-arabinofuranose] II
Following the same procedure as carried out for the preparation
C
20H32O3Si;C, 68.92; H, 9.25; Found: C, 68.65; H, 9.08.
of I, 12 (125 mg) was hydrogenated to afford pure II (70 mg, 90%)
as a thick oil. ½a D24
ꢂ
¼ ꢀ8:6 (c 1.4, MeOH) {lit.,6k
½
a 2D0
ꢂ
¼ ꢀ7:9 (c 1.2,
4.15. (1S,2S,3S,4R)-1-O-Benzyl-4-hydroxymethyl-cyclopentane-
1,2,3-triol 11
MeOH)}; 1H NMR (600 MHz D2O): d 1.22–1.26 (m, 1H), 1.73–1.79
(m, 1H), 2.07–2.12 (m, 1H), 3.39–3.42 (m, 1H), 3.54–3.57 (m,
1H), 3.60–3.65 (m, 2H), 3.92–3.95 (m, 1H); 13C NMR (150 MHz
D2O): 34.2, 45.3, 66.7, 72.5, 79.8, 80.9.
To a cooled (ꢀ78 °C) solution of 10c (348 mg, 1.0 mmol) in
CH2Cl2 (25 ml) was bubbled ozone gas until a blue color persisted.
To it was added PPh3 (300 mg, 1.15 mmol), and the blue color dis-
appeared immediately. The solution was brought to room temper-
ature and stirred for 40 min the solvent was removed from the
reaction mixture under reduced pressure. The residue was passed
through a short (200) silica gel column and quickly eluted with 0–
25% EtOAc in hexane to obtain an unstable aldehyde, which was ta-
ken in THF (25 ml). This solution was slowly added to a stirred sus-
pension of LiAlH4 (77 mg, 2.0 mmol) in THF (20 ml) at 10 °C. The
mixture was stirred for 1 h at 10 °C and then at room temperature
overnight. It was then cooled with ice water. The excess hydride
was decomposed by the dropwise addition of a saturated aqueous
solution of Na2SO4. The white precipitate formed was filtered and
washed with dry diethyl ether. The solvent was removed from
the combined washing under reduced pressure and the residue
was passed through a short (200) silica gel column and quickly
eluted with 0–10% MeOH/CHCl3 to obtain 11 (174 mg, 73.1%) as
a colorless oil, which was used as such for the next reaction. A por-
tion of the residue was subjected to spectral analysis for its charac-
References
1. (a) Berecibar, A.; Grandjean, C.; Siriwardena, A. Chem. Rev. 1999, 99, 779; (b)
Yoshikuni, Y. Trends Glycosci. Glycotechnol. 1991, 3, 184.
2. (a) Crimmins, M. T. Tetrahedron 1998, 40, 9229. and references cited therein;
(b) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319. and references cited
therein; (c) Amblard, F.; Nolan, S. P.; Agrofolio, L. A. Tetrahedron 2005, 61, 7067;
(d) Rodriquez, J. B.; Comin, M. J. Mini-Rev. Med. Chem. Tetrahedron 2003, 3, 95;
(e) Borthwick, A. D.; Biggadlike, K. Tetrahedron 1992, 48, 571; (f) Schnellar, S. W.
Curr. Top. Med. Chem. 1807, 2002, 2; (g) Agrofoglio, L.; Suhas, E.; Fareses, A.;
Condom, R.; Challand, S.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50, 10611; (h)
De Clercq, E. Nat. Rev. Drug Discovery 2002, 1, 13. and references cited therein;
(i) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
3. Collins, P. V.; Djuric, S. W. Chem. Rev. 1993, 93, 1533.
4. (a) Arjona, O.; Gomez, A. M.; Lopez, J. C.; Plumet, J. Chem. Rev. 2007, 107, 1919.
and references cited therein; (b) Suami, T.; Ogawa, S. Adv. Carbohydr. Chem.
Biochem. 1990, 48, 21. and references cited therein; (c) Marquez, V. E.; Lim, M.
Med. Res. Rev. 1986, 6, 1; (d) Hudlicky, T.; Cwbulak, M. Cyclitol and Their
Derivatives. A Handbook of Physical, Spectral and Synthetic Data; VCH: New York,
1993; (e) Nishimura, Y. In Studies in Natural Products Chemistry; Atta-ur-
Rahman, Ed.; Elsevier Publishers B.V.: Amsterdam, 1992; p 495.
5. (a) Yaginuma, S.; Muto, N.; Tsujino, M.; Sudate, Y.; Hayashi, M.; Otani, M. J.
Antibiot. 1981, 34, 359; (b) Kusaka, T.; Yamamoto, H.; Shibata, M.; Muroi, M.;
Kishi, T.; Mizuno, K. J. Antibiot. 1968, 21, 255.
6. (a) Wilcox, C. S.; Gaudino, J. J. J. Am. Chem. Soc. 1986, 108, 3102; (b) Gaudino, J.
J.; Wilcox, C. S. Carbohydr. Res. 1990, 206, 233; (c) Tadano, K.; Hoshimo, M.;
Ogawa, S.; Suami, T. J. Org. Chem. 1988, 53, 1427; (d) Marschner, C.;
Baumgartner, J.; Griengi, H. J. Org. Chem. 1995, 60, 5224. and references cited
therein; (e) Wagner, S. H.; Lundt, I. J. Chem. Soc., Perkin Trans. 1 2001, 780; (f)
terization.
½
a 2D7
ꢂ
¼ þ22:0 (c 1.09, CH2Cl2); 1H NMR (700 MHz
CDCl3): d 1.77 (dt, J = 12.0 Hz, 6.0 Hz, 1H), 1.89 (m, 1H), 2.50 (m,
1H), 2.97(br s, 2H), 3.46 (br s, 1H), 3.63–3.65 (m, 1H), 3.76–3.77
(m, 1H), 3.94 (m, 1H), 4.03(m, 1H), 4.25 (t, J = 5.6 Hz, 1H), 4.48,
4.59 (AB q, J = 11.9 Hz, 2H), 7.26–7.35 (m, 5H); 13C NMR